Ausgabe 2/2016
Inhalt (10 Artikel)
Biomarkers (S Dawood, Section Editor)
Comprehensive Gene Mutation Profiling of Breast Tumors: Is It Ready for Prime Time Use?
Vaibhav Choudhary, Sudeep Gupta
Biomarkers (S Dawood, Section Editor)
Emerging Biomarkers of the Future: Changing Clinical Practice for 2020
Hazem I. Assi, Rita E. Assi, Nagi S. El Saghir
Biomarkers (S Dawood, Section Editor)
Defining the Prognostic and Predictive Role of PIK3CA Mutations: Sifting Through the Conflicting Data
Sana Al-Sukhun, Isam Lataifeh, Rajaa Al-Sukhun
Local-Regional Evaluation and Therapy (EP Mamounas, Section Editor)
Role of Breast MRI in Patients with Newly Diagnosed Breast Cancer
Marissa L. Albert, Yiming Gao, Linda Moy
Local-Regional Evaluation and Therapy (EP Mamounas, Section Editor)
Nipple-Sparing Mastectomy in Patients with Germline BRCA Mutations: Is it Safe?
Richard Gilmore, David M. Euhus
Local-Regional Evaluation and Therapy (EP Mamounas, Section Editor)
Regional Nodal Radiotherapy in Early-Stage Breast Cancer: Where Are We in 2016?
Robert T. Dess, Corey W. Speers, Lori J. Pierce
Local-Regional Evaluation and Therapy (EP Mamounas, Section Editor)
The Optimal Approach to Post-Mastectomy and Post-Lumpectomy Breast Reconstruction
Merisa L. Piper, Hani Sbitany
Open Access
Local-Regional Evaluation and Therapy (EP Mamounas, Section Editor)
Oncoplastic Breast Surgery: What, When and for Whom?
R. Douglas Macmillan, Stephen J. McCulley
Local-Regional Evaluation and Therapy (EP Mamounas, Section Editor)
New Developments in Assessing Risk of Local Recurrence in Patients with Ductal Carcinoma In Situ after Lumpectomy and Breast Radiation
Nafisha Lalani, Sharon Nofech-Mozes, Eileen Rakovitch
Local-Regional Evaluation and Therapy (EP Mamounas, Section Editor)
Margins in Breast-Conserving Surgery for Early Breast Cancer: How Much is Good Enough?
Nehmat Houssami, M. Luke Marinovich